HomeVLA • EPA
add
Valneva SE
Nakaraang pagsara
€3.73
Sakop ng araw
€3.67 - €3.72
Sakop ng taon
€2.05 - €5.42
Market cap
640.29M EUR
Average na Volume
821.81K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 29.41M | -35.82% |
Gastos sa pagpapatakbo | 15.56M | 13.89% |
Net na kita | -44.36M | -380.24% |
Net profit margin | -150.82 | -648.12% |
Kita sa bawat share | -0.60 | -297.27% |
EBITDA | -31.96M | -326.31% |
Aktuwal na % ng binabayarang buwis | -2.03% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 143.46M | -8.23% |
Kabuuang asset | 448.23M | -13.24% |
Kabuuang sagutin | 297.75M | -0.47% |
Kabuuang equity | 150.48M | — |
Natitirang share | 181.05M | — |
Presyo para makapag-book | 4.49 | — |
Return on assets | -20.28% | — |
Return on capital | -25.59% | — |
Cash Flow
Net change in cash
| (EUR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -44.36M | -380.24% |
Cash mula sa mga operasyon | -17.44M | -66.39% |
Cash mula sa pag-invest | 197.00K | 101.28% |
Cash mula sa financing | -556.00K | -101.07% |
Net change in cash | -17.84M | -171.60% |
Malayang cash flow | -16.25M | 39.99% |
Tungkol
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Itinatag
2013
Website
Mga Empleyado
700
